Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
30 34 Search
2025
Burdock Fructooligosaccharide Protects Against Diabetic Nephropathy in Mice by Regulating Nrf2 Signaling
Pharmacology Research & Perspectives
2025
Potential renoprotective effects and possible underlying mechanisms of angiotensin receptor-neprilysin inhibitors in cardiorenal syndrome
Frontiers in Medicine
2025
Role of sacubitril/valsartan in testicular ischaemia reperfusion injury via modulation of AngII/ASK/NF‐κB and JAK/STAT pathways in juvenile rats
British Journal of Pharmacology
2025
BOLD MRI to Evaluate the Effects of Sacubitril/Valsartan on Renal Protection in Type 2 Diabetics
Diabetes, Metabolic Syndrome and Obesity
2025
LCZ696 improves oxidative stress injury in human podocytes induced by increased glucose levels via Nrf2/HO-1 signaling pathway
European Journal of Medical Research
2024
Inflammation in heart failure: pathophysiology and therapeutic strategies
Inflammation Research
2024
Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction
Kidney Research and Clinical Practice
2024
Unveiling Wide Spectrum Therapeutic Implications and Signaling Mechanisms of Valsartan in Diverse Disorders: A Comprehensive Review
Current Drug Research Reviews
2024
NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies
Heliyon
2023
Protective effect of eriodictyol against hyperglycemia-induced diabetic nephropathy in rats entails antioxidant and anti-inflammatory effects mediated by activating Nrf2
Saudi Pharmaceutical Journal
2023
The angiotensin receptor neprilysin inhibitor LCZ696 attenuates renal fibrosis via ASK1/JNK/p38 MAPK-mediated apoptosis in unilateral ureteral obstruction
PLOS ONE
2023
LCZ696 (sacubitril/valsartan) mitigates cyclophosphamide-induced premature ovarian failure in rats; the role of TLR4/NF-κB/NLRP3/Caspase-1 signaling pathway
Life Sciences
2023
Protective role of Dodonaea viscosa extract against streptozotocin-induced hepatotoxicity and nephrotoxicity in rats
Saudi Pharmaceutical Journal
2023
Local anaesthetic procaine derivatives protect rat against diabetic nephropathy via inhibition of DPP‐4, inflammation and oxidative stress
Chemical Biology & Drug Design
2023
Effect of Sacubitril-Valsartan on Antihypertensive Efficacy Inflammatory Factors in Elderly Patients with Hyperten-sion
Advances in Clinical Medicine
2023
Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
Frontiers in Immunology
2022
The Role of NF-κB and Bax/Bcl-2/Caspase-3 Signaling Pathways in the Protective Effects of Sacubitril/Valsartan (Entresto) against HFD/STZ-Induced Diabetic Kidney Disease
Biomedicines
2022
Potential effects and application prospect of angiotensin receptor-neprilysin inhibitor in diabetic kidney disease
Journal of Diabetes and its Complications
2022
LCZ696 Ameliorates Isoproterenol-Induced Acute Heart Failure in Rats by Activating the Nrf2 Signaling Pathway
Applied Bionics and Biomechanics
2022
LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats
Scientific Reports
2022
The effects of supplementation of Nannochloropsis oculata microalgae on biochemical, inflammatory and antioxidant responses in diabetic rats
Biomolecular Concepts
2022
Sacubitril/valsartan combination enhanced cardiac glycophagy and prevented the progression of murine diabetic cardiomyopathy
Biomedicine & Pharmacotherapy
2022
Sacubitril/Valsartan Improves Progression of Early Diabetic Nephropathy in Rats Through Inhibition of NLRP3 Inflammasome Pathway
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
2022
The Effect of Sacubitril/Valsartan Treatment on Cardiac and Renal Functions of a Patient With Cardiorenal Syndrome Type 4 and Stage 5 CKD After More Than Three Years of Follow-Up
Frontiers in Medicine
2021
Inhibition of neprilysin with sacubitril without RAS blockage aggravates renal disease in Dahl SS rats
Renal Failure
2021
Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice compared with valsartan treatment
American Journal of Physiology-Renal Physiology
2021
Sacubitril/valsartan treatment relieved the progression of established pulmonary hypertension in rat model and its mechanism
Life Sciences
2021
TaleNeprilysin and Neprilysin inhibition in chronic kidney disease
Current Opinion in Nephrology & Hypertension
2020
Coadministration of Ketamine and Perampanel Improves Behavioral Function and Reduces Inflammation in Acute Traumatic Brain Injury Mouse Model
BioMed Research International
2020
Reviews of Physiology, Biochemistry and Pharmacology
Additional cited-by details will be shown when available from Crossref